scispace - formally typeset
S

Seyed-Alireza Esmaeili

Researcher at Mashhad University of Medical Sciences

Publications -  68
Citations -  3373

Seyed-Alireza Esmaeili is an academic researcher from Mashhad University of Medical Sciences. The author has contributed to research in topics: Medicine & Immune system. The author has an hindex of 15, co-authored 45 publications receiving 1666 citations.

Papers
More filters
Journal ArticleDOI

Macrophage plasticity, polarization, and function in health and disease.

TL;DR: The protective and pathogenic role of the macrophage subsets in normal and pathological pregnancy, anti‐microbial defense, anti-tumor immunity, metabolic disease and obesity, asthma and allergy, atherosclerosis, fibrosis, wound healing, and autoimmunity are discussed.
Journal ArticleDOI

Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease.

TL;DR: Cardioprotective exosomal miRs secreted by transplanted stem cells from various sources, including embryonic stem cells, induced pluripotent stem cells (iPSCs), mesenchymalstem cells (MSCs), and cardiac stem/progenitor cells, showed beneficial modulatory effects on the myocardial infracted heart.
Journal ArticleDOI

Curcumin: A natural modulator of immune cells in systemic lupus erythematosus.

TL;DR: The results of in vitro, experimental, and clinical studies pertaining to the modulatory effects that curcumin produces on the function and numbers of dendritic cells and T cell subsets, as well as relevant cytokines that participate in SLE are reviewed.
Journal ArticleDOI

A Review on the Pharmacology and Toxicology of Steviol Glycosides Extracted from Stevia rebaudiana.

TL;DR: The present review provides a summary on the biological and pharmacological properties of steviol glycosides that might be relevant for the treatment of human diseases.
Journal ArticleDOI

Ovarian cancer stem cells and targeted therapy.

TL;DR: The present review summarized the recent findings about the role of CSCs in tumor relapse and drug resistance among ovarian cancer patients and focused on the targeted and combinational therapeutic methods against the ovarian C SCs.